Tag: pharmaceuticals
-

Light-Activated Therapy Improves Vision in Inherited Disease Trial
A clinical trial shows a light-activated protein from an injected gene improves visual abilities in people with advanced retinitis pigmentosa, an inherited eye disorder.
-

Low-Dose Covid-19 Vaccine Generates Strong Immune Response
Ultra-low quantities of an experimental Covid-19 protein vaccine delivered in synthetic cell components are shown in lab animals to generate strong immune responses.
-

Real World Evidence Shown to Emulate Some Clinical Trials
A study of insurance claims records matching the design of randomized clinical trials shows claims data can in some cases resemble clinical trial results to make causal inferences.
-

Trial Shows Plant-Based Drug Helps Reduce Vaping
First results of a clinical trial show a drug derived from plants to aid in smoking cessation helps cut the use of e-cigarettes among non-smokers of burning tobacco.
-

Cancer Cell Therapy Biotech Launches, Raises $10M
A start-up company with a process for harvesting large quantities of cells that infiltrate and kill solid tumors is raising $10 million in seed venture funds.
-

Biotech Group Blasts Reproductive Drug Ruling
A biotechnology industry group calls Friday’s ruling in a Federal district court to suspend approval of the drug mifepristone “an assault on science.”
-

Health, Tech Venture Investor Adds $850M Fund
A venture capital company specializing in early-stage investments in life science, health, and technology start-ups announced a new $850 million fund.
-

Trial Okayed for Glaucoma Treatment Implant
A developer of treatments for eye diseases says it received clearance from FDA to begin a clinical trial of a sustained-release implant therapy for glaucoma.
-

Investor Backing Nanotech Drug Discovery Advances
A life science venture investor is funding further development of a lower-cost molecular-level drug discovery process using nanoscale synthetic DNA strands.
-

Biotechs Partner to Boost mRNA Manufacturing
Two companies working in synthetic biology are advancing a new process they say increases the scale and reduces costs of messenger RNA manufacturing.